Literature DB >> 19135409

Spectrophotometric study for the reaction between fluvoxamine and 1,2-naphthoquinone-4-sulphonate: Kinetic, mechanism and use for determination of fluvoxamine in its dosage forms.

Ibrahim A Darwish1, Heba H Abdine, Sawsan M Amer, Lama I Al-Rayes.   

Abstract

Spectrophotometric study was carried out, for the first time, to investigate the reaction between the antidepressant fluvoxamine (FXM) and 1,2-naphthoquinone-4-sulphonate (NQS) reagent. In alkaline medium (pH 9), an orange-colored product exhibiting maximum absorption peak (lambda(max)) at 470nm was produced. The kinetics of the reaction was investigated and its activation energy was found to be 2.65kcalmol(-1). Because of this low activation energy, the reaction proceeded easily. The stoichiometry of the reaction was determined and the reaction mechanism was postulated. This color-developing reaction was successfully employed in the development of simple and rapid spectrophotometric method for determination of FXM in its pharmaceutical dosage forms. Under the optimized reaction conditions, Beer's law correlating the absorbance (A) with FXM concentration (C) was obeyed in the range of 0.6-8microgml(-1). The regression equation for the calibration data was A=0.0086+0.1348C, with good correlation coefficient (0.9996). The molar absorptivity (epsilon) was 5.9x10(4)lmol(-1)cm(-1). The limits of detection and quantification were 0.2 and 0.6microgml(-1), respectively. The precision of the method was satisfactory; the values of relative standard deviations did not exceed 2%. The proposed method was successfully applied to the determination of FXM in its pharmaceutical tablets with good accuracy and precisions; the label claim percentage was 100.47+/-0.96%. The results obtained by the proposed method were comparable with those obtained by the official method. The proposed method is superior to all the previously reported spectrophotometric methods for determination of FXM in terms of its simplicity and sensitivity. The method is practical and valuable for its routine application in quality control laboratories for analysis of FXM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135409     DOI: 10.1016/j.saa.2008.12.009

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  5 in total

1.  New spectrofluorimetric method for determination of cephalosporins in pharmaceutical formulations.

Authors:  Abdalla A Elbashir; Shazalia M Ali Ahmed; Hassan Y Aboul-Enein
Journal:  J Fluoresc       Date:  2011-12-10       Impact factor: 2.217

2.  Use of response surface methodology for development of new microwell-based spectrophotometric method for determination of atrovastatin calcium in tablets.

Authors:  Tanveer A Wani; Ajaz Ahmad; Seema Zargar; Nasr Y Khalil; Ibrahim A Darwish
Journal:  Chem Cent J       Date:  2012-11-12       Impact factor: 4.215

3.  Novel spectrophotometric method for determination of cinacalcet hydrochloride in its tablets via derivatization with 1,2-naphthoquinone-4-sulphonate.

Authors:  Ibrahim A Darwish; Mona M Al-Shehri; Manal A El-Gendy
Journal:  Chem Cent J       Date:  2012-02-03       Impact factor: 4.215

4.  Novel microwell-based spectrophotometric assay for determination of atorvastatin calcium in its pharmaceutical formulations.

Authors:  Tanveer A Wani; Nasr Y Khalil; Hamdy M Abdel-Rahman; Ibrahim A Darwish
Journal:  Chem Cent J       Date:  2011-10-07       Impact factor: 4.215

5.  Studying the association complex formation of atomoxetine and fluvoxamine with eosin Y and its application in their fluorimetric determination.

Authors:  Sayed M Derayea; Mahmoud A Omar; Ahmed A Abu-Hassan
Journal:  R Soc Open Sci       Date:  2018-03-14       Impact factor: 2.963

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.